CD103+ tumor-infiltrating lymphocytes are tumor-reactive intraepithelial CD8+ T cells associated with prognostic benefit and therapy response in cervical cancer.
Human papilloma virus (HPV)-induced cervical cancer constitutively expresses viral E6/E7 oncoproteins and is an excellent target for T cell-based immunotherapy. However, not all tumor-infiltrating T cells confer equal benefit to patients, with epithelial T cells being superior to stromal T cells. To...
Egile Nagusiak: | Komdeur, F, Prins, T, van de Wall, S, Plat, A, Wisman, G, Hollema, H, Daemen, T, Church, D, de Bruyn, M, Nijman, H |
---|---|
Formatua: | Journal article |
Hizkuntza: | English |
Argitaratua: |
Taylor and Francis
2017
|
Antzeko izenburuak
-
CD103+ tumor-infiltrating lymphocytes are tumor-reactive intraepithelial CD8+ T cells associated with prognostic benefit and therapy response in cervical cancer
nork: Fenne L. Komdeur, et al.
Argitaratua: (2017-09-01) -
Tumor infiltrating CD8/CD103/TIM-3-expressing lymphocytes in epithelial ovarian cancer co-express CXCL13 and associate with improved survival
nork: Martijn Vlaming, et al.
Argitaratua: (2022-10-01) -
Combined STING levels and CD103+ T cell infiltration have significant prognostic implications for patients with cervical cancer
nork: Arjan Kol, et al.
Argitaratua: (2021-01-01) -
A transcriptionally distinct CXCL13+ CD103+ CD8+ T-cell population is associated with B-cell 2 recruitment and neoantigen load in human cancer
nork: Workel, H, et al.
Argitaratua: (2019) -
Development of [89Zr]Zr-hCD103.Fab01A and [68Ga]Ga-hCD103.Fab01A for PET imaging to noninvasively assess cancer reactive T cell infiltration: Fab-based CD103 immunoPET
nork: Xiaoyu Fan, et al.
Argitaratua: (2023-11-01)